Neoplastic Progression of Barrett’s Esophagus Among Organ Transplant Recipients: a Retrospective Cohort Study

[1] Marques de Sá I(2020)The global prevalence of Barrett's esophagus: A systematic review of the published literature. United European Gastroenterol J. 8 1086-1105

[2] Marcos P(2019)Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium Gastrointest Endosc. 89 257-263.e3

[3] Sharma P(2020)Risk Factors for Progression of Barrett's Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma Sci Rep. 10 4899-54

[4] Dinis-Ribeiro M(2012)Increased incidence of endoscopic erosive esophagitis in solid organ transplant recipients Gut Liver. 6 349-1023

[5] Desai M(2019)Prevalence and Natural History of Barrett's Esophagus in Lung Transplant: A Single-Center Experience Ann Thorac Surg. 107 1017-3

[6] Lieberman DA(2015)Successful surgical management of early esophageal cancer in a patient with cystic fibrosis post-bilateral lung transplantation BMJ Case Rep. 2015 bcr2015210342-8

[7] Kennedy KF(2011)Progression to adenocarcinoma in Barrett's esophagus after liver transplantation Transplantation. 91 1250-3

[8] Hamade N(2010)Rapid progression of Barrett's esophagus into adenocarcinoma in a combined lung and kidney transplant recipient J Thorac Cardiovasc Surg. 139 217-46

[9] Thota P(1999)Rapid progression to high-grade dysplasia in Barrett's esophagus after liver transplantation Liver Transpl Surg. 5 332-52

[10] Parasa S(2010)Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age Liver Transpl. 16 837-30

[1] Marques de Sá I(2020)The global prevalence of Barrett's esophagus: A systematic review of the published literature. United European Gastroenterol J. 8 1086-1105

[2] Marcos P(2019)Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium Gastrointest Endosc. 89 257-263.e3

[3] Sharma P(2020)Risk Factors for Progression of Barrett's Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma Sci Rep. 10 4899-54

[4] Dinis-Ribeiro M(2012)Increased incidence of endoscopic erosive esophagitis in solid organ transplant recipients Gut Liver. 6 349-1023

[5] Desai M(2019)Prevalence and Natural History of Barrett's Esophagus in Lung Transplant: A Single-Center Experience Ann Thorac Surg. 107 1017-3

[6] Lieberman DA(2015)Successful surgical management of early esophageal cancer in a patient with cystic fibrosis post-bilateral lung transplantation BMJ Case Rep. 2015 bcr2015210342-8

[7] Kennedy KF(2011)Progression to adenocarcinoma in Barrett's esophagus after liver transplantation Transplantation. 91 1250-3

[8] Hamade N(2010)Rapid progression of Barrett's esophagus into adenocarcinoma in a combined lung and kidney transplant recipient J Thorac Cardiovasc Surg. 139 217-46

[9] Thota P(1999)Rapid progression to high-grade dysplasia in Barrett's esophagus after liver transplantation Liver Transpl Surg. 5 332-52

[10] Parasa S(2010)Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age Liver Transpl. 16 837-30